Related Experiment Video
Updated: Aug 7, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Inhibition of breast cancer growth and invasion by single-minded 2s
Hyeong-Il Kwak1, Tanya Gustafson, Richard P Metz
1Department of Integrated Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843-4458, USA.
Abstract:
Single-minded 2 (SIM2) is a member of the bHLH-PAS family of transcription factors. SIM2 was initially identified by positional cloning on chromosome 21 and is thought to contribute to the etiology of trisomy-21 [Down syndrome (DS)]. In addition to the physical and mental deficiencies associated with this genetic disease, it has become apparent that women with DS are 10-25 times less likely to die from breast cancer in comparison with age-matched normal populations. This is thought to be a result of gene dosage effect of tumor suppressor genes on chromosome 21. Here, we report that a splice variant of SIM2, SIM2 short (SIM2s), is differentially expressed in normal breast and breast cancer-derived cell lines and is downregulated in human breast cancer samples. Re-establishment of SIM2s in MDA-MB-435 breast cancer cells significantly reduced proliferation, anchorage-independent growth and invasive potential. Consistent with its role as a transcriptional repressor, SIM2s directly decreased expression of matrix metalloprotease-3, a known mediator of breast cancer metastasis. These results suggest that SIM2s has breast tumor suppressive activity.
Insights
The Single-minded 2 short (SIM2s) variant acts as a tumor suppressor, inhibiting breast cancer cell growth and metastasis. Its downregulation in breast cancer suggests a protective role against the disease.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Single-minded 2 (SIM2) is a transcription factor linked to Down syndrome (DS).
- Women with DS exhibit a reduced incidence of breast cancer, potentially due to chromosome 21 gene dosage effects.
- A SIM2 splice variant, SIM2 short (SIM2s), is investigated for its role in breast cancer.
Purpose of the Study:
- To investigate the expression and function of SIM2s in breast cancer.
- To determine if SIM2s possesses tumor suppressive properties.
Main Methods:
- Differential expression analysis of SIM2s in breast cell lines and human samples.
- Functional assays in breast cancer cells (MDA-MB-435) to assess proliferation, anchorage-independent growth, and invasion.
- Analysis of SIM2s' effect on matrix metalloprotease-3 (MMP-3) expression.
Main Results:
- SIM2s is differentially expressed in breast cancer cell lines and downregulated in human breast cancer tissues.
- Restoring SIM2s expression in cancer cells significantly reduced proliferation, anchorage-independent growth, and invasiveness.
- SIM2s directly repressed MMP-3 expression, a key mediator of breast cancer metastasis.
Conclusions:
- SIM2s exhibits significant breast tumor suppressive activity.
- The findings suggest SIM2s could be a potential therapeutic target for breast cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
Abnormal Proliferation

